ProKidney Corp [PROK] stock is trading at $0.79, down -0.63%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The PROK shares have gain 28.92% over the last week, with a monthly amount drifted -20.19%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Guggenheim started tracking the stock with Buy rating on September 10, 2024, and set its price target to $6. BofA Securities downgraded its rating to a Neutral. BTIG Research initiated its recommendation with a Buy and recommended $16 as its price target on July 25, 2023. Jefferies started tracking with a Buy rating for this stock on December 21, 2022, and assigned it a price target of $15. In a note dated November 10, 2022, Morgan Stanley initiated an Equal-Weight rating and provided a target price of $13 on this stock.
ProKidney Corp [PROK] stock has fluctuated between $0.46 and $4.44 over the past year. Currently, Wall Street analysts expect the stock to reach $4.67 within the next 12 months. ProKidney Corp [NASDAQ: PROK] shares were valued at $0.79 at the most recent close of the market. An investor can expect a potential return of 491.14% based on the average PROK price forecast.
Analyzing the PROK fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.23, Equity is 0.1 and Total Capital is -0.45. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.7050 points at the first support level, and at 0.6190 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.8819, and for the 2nd resistance point, it is at 0.9728.
Ratios To Look Out For
For context, ProKidney Corp’s Current Ratio is 10.93. Further, the Quick Ratio stands at 10.93, while the Cash Ratio is 2.74. Considering the valuation of this stock, the price to sales ratio is 2893.62.
Transactions by insiders
Recent insider trading involved Control Empresarial de Capital, Add’l Rep. Persons-see Ex.99-1, that happened on Apr 16 ’25 when 100000.0 shares were purchased. Add’l Rep. Persons-see Ex.99-1, Control Empresarial de Capital completed a deal on Apr 15 ’25 to buy 0.47 million shares. Meanwhile, Add’l Rep. Persons-see Ex.99-1 Control Empresarial de Capital bought 0.27 million shares on Apr 14 ’25.
